Although the effect of interferon inducers on the outcome of virus infections has been extensively studied, only a few studies of their effect on viremia have been reported. Lactic dehydrogenase virus (LDV) is a togavirus (15) 24 h after infection) which persists at lower levels (about 101 ID.0/ml) for the lifetime of the mouse (17) . LDV replicates in macrophages in vivo (7, 22, 26) and in vitro (7, 12) .
A few weeks after infection, neutralizing antibody (10, 16, 24) and infectious antigen antibody complexes (10, 16) can be detected in the plasma. These complexes are deposited in the kidneys and a mild glomerulonephritis can be detected (19, 21) . In these respects LDV is similar to Aleutian disease virus (ADV) and several other persistent viruses (20) . For these reasons LDV represents a useful model for the study of the effect of interferon inducers on such viruses. The present communication reports the effect of single and multiple injections of polyinosinicpolycytidylic acid [poly(I) -poly(C) ] on LDV viremia in mice.
MATERIALS AND METHODS
Animals. Random-bred Swiss albino mice (18 to 22 g female) were supplied by the animal production section of the National Institutes of Health.
Virus. The strain of LDV used was isolated in our laboratory from a naturally infected Ehrlich ascites carcinoma carried in CDF1 mice (6) . Stock LDV was obtained from the 5th and 6th passage of this virus in Swiss albino mice. Mice were infected with 10" ID,,, per dose and serum was collected 24 h later. The titer of the stock serum pools was about 1010 ID,0/ml. Poly(I).poly(C). Poly(I) and poly(C) were purchased from P-L Biochemicals and annealed as previously described (9) .
Virus titration. LDV was titered by measuring the rise in blood plasma lactic dehydrogenase levels of five mice per dilution as described before (8) . The ID,, per milliliter was calculated by the method of Karber (see reference 14) .
Interferon titrations. Interferon was titered by the GD-7 virus hemagglutinin yield reduction method on mouse L cells as described previously (18) .
Injections. All injections were by the intraperitoneal route unless otherwise stated.
Bleeding. Heparinized blood plasma was collected by the orbital bleeding technique (23) . compared with the titers of the nontreated controls. After this period, from 2 until 8 days after infection, the virus titers were the same as in the control mice, although moderate levels of serum interferon persisted for at least 7 days. The difference in serum interferon levels between the two poly(I) -poly(C)-treated groups is not as great as it appears because the timing of the sampling was such that in the group receiving poly(I) .poly(C) at 24-h intervals interferon levels had fallen to a minimum. The moderate level of serum interferon found in the control group during the first 3 days is consistent with previous reports of LDV-induced interferon (2, 11) .
RESULTS

Prophylactic
Therapeutic treatment with poly(I)* poly(C). The effect of therapy with repeated doses of poly(I) poly(C), beginning 24 h after infection with 106 ID50 of LDV, is presented in Fig. 4 and 5. In the first experiment (Fig. 4) , six doses of 100 ,ug of poly(I) -poly(C) were given at 24-h intervals. This dosage schedule caused a 1-to 2-log decrease in viremia beginning at 48 h after the start of treatment and lasting at least 24 h after cessation of (1) . However, only a few studies of the effect of interferon and interferon inducers on viremia have been reported. We have previously shown that interferon induced by Newcastle disease virus caused a temporary decrease (3 to 4 days) in the chronic stage of LDV viremia (6) . Similar results were found in a study with West Nile virus using a single dose of poly(I) -poly(C) as the interferon inducer (13) . In another study a single dose of statolon given at 6 h before infection caused a significant reduction in LDV viremia at 24 h after infection, however no assays at later times were performed (4) . More recent studies in our laboratory have shown that repeated doses of large amounts of exogenous interferon can also cause a small reduction in LDV viremia (5) .
The present results indicate that prophylactic treatment with either single or multiple injection of a potent interferon inducer [poly(I) -poly(C) ] causes a significant (2.5 to 4.0 log10) but temporary decrease in LDV viremia in mice. The failure to obtain a prolonged reduction in titer may be due to a secondary effect of poly(I) -poly(C) on the LDV target cells (macrophages), and/or to a partial hyporesponsiveness of interferon induction after repeated injections of poly(I) -poly(C) (3, 9) . Support for the first suggestion comes from the observation that a dosage schedule of 200 Ag every 48 h caused a delayed maximal viremia at 72 h which was higher than the control maximum at 24 h (Fig. 2) . Support for the second suggestion comes from the observation that only moderate levels of interferon were found for 7 days (Fig.  3) . In contrast, therapeutic treatment with multiple injections of poly(I) -poly(C) caused a prolonged decrease in viremia of 1.0 to 2.0 log10.
At the present time we have no satisfactory explanation for this discrepancy.
It is interesting to note that an increase of the poly(I) poly(C) dose from 100 gg every 24 h to 100 gg every 12 h was not more effective in reducing the LDV titer, even though a somewhat higher level of serum interferon was maintained ( Fig. 3 ) (see also references 3 and 9). This may be due to a lack of correlation between the amount of serum interferon and the level of protection. However, since the higher dose approaches the toxic level of poly(I) poly(C) (27) (27) and in another study with encephalomyocarditis virus (25) .
We have proposed previously that the relatively rapid decline in LDV viremia during the first few days of infection may be due to the LDV-induced interferon present at this time (5) . Further support for this theory comes from the observation that when poly(I) -poly(C) therapy was started 24 h after infection there was a 48-to 72-h lag period before the viremia was reduced below the control level (Fig. 4, 5) . In contrast, when poly(I) -poly(C) therapy was started at 20 days postinfection (Fig. 6 ) or when prophylactic treatment was given ( Fig. 1-3 ), no lag period was observed.
